Linda Wittkop

11PUBLICATIONS
62CO-AUTHORS
Disease surveillanceEpidemiological modellingNanotoxicology, health and safetyMajor global burdens of diseaseRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 18, 2025
Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV.

Daniela K van Santen, Mathieu Chalouni, Juan Berenguer

|Dec 31, 2024
HIV prevention and missed opportunities among people with recently acquired HIV infection: Α protocol for a systematic review.

Argyro Karakosta, Elisa Ruiz-Burga, Shema Tariq

|Jul 17, 2024
Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America.

Julie Ambia, Suzanne M Ingle, Kathleen McGinnis

|May 31, 2024
Definition of Virological Endpoints Improving the Design of HIV Cure Strategies Using Analytical Antiretroviral Treatment Interruption.

Marie Alexandre, Mélanie Prague, Edouard Lhomme

|Jul 02, 2021
Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants.

Mathieu Chalouni, Linda Wittkop, Firouzé Bani-Sadr

|Aug 19, 2020
Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH).

Marion Mora, Trevor Goodyear, Fabienne Marcellin

Pageof 2

Frequent Collaborators

3 joint publications

Juan Berenguer

2 joint publications

Marc Van der Valk

2 joint publications

Jim Young

2 joint publications

Mathieu Chalouni